Vitrolife AB
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Bronwyn Brophy O'Connor
- Full Time Employees
- 1,151
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Gustaf Werners gata 2 Gothenburg VG Sweden 421 32
- IPO Date
- Jun 19, 2001
- Website
- vitrolife.com
- Similar Companies
- Business
- Vitrolife AB is a Sweden-based developer, manufacturer, and provider of advanced life science and reproductive health solutions, specializing in cellular therapies and assisted reproduction technologies. The company focuses on product categories including ART media and equipment; cell culturing and embryo transfer systems; embryo biopsy and vitrification media; sperm preparation and semen analysis tools; diagnostic assays and related consumables; and laboratory automation solutions. Vitrolife operates through multiple brands and product lines designed to support fertility clinics, embryology laboratories, and research institutions. Latest major company changes include recent strategic partnerships and collaborations within the fertility and biotechnology sectors; expansion of product offerings through new ART media formulations and associated consumables; ongoing acquisitions and integrations to broaden portfolio and geographic reach; and organizational refinements to support accelerated product development and market penetration across key regions. Industry context and segments: fertility solutions, assisted reproduction technology, cellular therapy support, laboratory consumables and equipment; target markets include fertility clinics, hospitals, research institutions, and biopharma partners. Geographic footprint spans Europe, North America, Asia-Pacific, and other regions, with headquarters in Gothenburg, Sweden, and founding year dating to the late 20th century. Subsidiaries and parent-company relationships align Vitrolife with a network of affiliated entities delivering global support, distribution, and regulatory compliance.
Company News
Vitrolife AB (publ) (OTCMKTS:VTRLY) Stock Price Up 7.8% – Should You Buy?
Vitrolife AB (publ) (VTRLY) Q2 2026 Earnings Call Transcript
Report from the Annual General Meeting of Vitrolife AB (publ)
Vitrolife AB (publ) (VTRLY) Q1 2026 Earnings Call Transcript
Vitrolife AB (publ) - Interim report Q1, 2026: Strong growth in Consumables and Technologies
Notice of the Annual General Meeting of Vitrolife AB (publ)
Vitrolife AB (publ) (VTRLY) Q4 2025 Earnings Call Transcript
Vitrolife AB (publ) - Fourth quarter and full year report 2025
Vitrolife AB (publ) (OTCMKTS:VTRLY) Shares Up 1.6% – Here’s What Happened
Vitrolife AB (publ) (OTCMKTS:VTRLY) Stock Price Down 16.4% – Should You Sell?
Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026